Neurol. praxi. 2010;11(2):104-106
Migraine and hormonal contraception
- Neurologická ambulance Quattromedica Brno a II. neurologická klinika LF MU a FN, Brno
Migraine in women is a hormonal conditioned diseases and its prevalence changes during the course of life. Migraines typically occur
during menses (menstrual migraine). Hormonal changes (pregnancy, lactation, perimenopause, menopause) influence their appearance
significantly. Women with menstrual migraine can profit from continual use of combined oral contraception (COC). Migraines with aura
in females is more likely to worsen due to COC and are higher at risk of migraine stroke, especially with those who smoke. Administration
of hormone replacement therapy leaves the frequency of preexisting migraine in more than half women unchanged. Estrogen
replacement can be provocative for migraines with aura or isolated aura. Continuous regimen is recommended in combined hormone
replacement therapy.
Keywords: migraine, estrogens, progestins, hormonal contraception
Published: April 1, 2010 Show citation
References
- Bouser MG, Conard J, Kittner S, Lignieres deB, MacGregor EA, Massiou H, Silberstein SD, Tyourio C. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia 2000; 20: 155-156.
Go to original source... 
Go to PubMed... - Čepický P. Doporučení WHO k užívání kombinované hormonální antikoncepce 2004. Moderní gynekologie a porodnictví 2005; 14(1)Suppl.: 11-26.
- Hodson J, Thompson J, al-Azzawi F. Headache at menopause and in hormone replacement therapy users. Climacteric. 2000; 3(2): 119-124. Go to original source... Go to PubMed...
- Hutchinson S, Peterlin BL. Menstrual Migraine. New York: Oxford University Press 2008: 95.
- Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005; 330(7482): 63. Go to original source... Go to PubMed...
- Křepelka P. Estrogendeficitní syndrom, klimakterium a HRT. Dostupný z WWW: http://www.euni.
- Křepelka P. Kombinovaná hormonální kontracepce. Dostupný z WWW: http://www.euni.
- Lidegaard O, Kreiner S. Contraceptives and cerebral thrombosis: A five-year national case-control study. Contraception. 2002; 65(3): 197-205. Go to original source... Go to PubMed...
- Loder EW, Buse DC, Golub JR. Headache and combination estrogen-progestin oral contraceptive: Integrating evidence, guidelines, and clinical practice. Headache 2005; 45: 224-231. Go to original source... Go to PubMed...
- Martin VT, Behbehani M. Ovarian hormons and migraine headache: Understanding mechanisms and pathogenesis - part 1. Headache 2006; 46: 3-23. Go to original source... Go to PubMed...
- Martin VT, Behbehani M. Ovarian hormons and migraine headache: Understanding mechanisms and pathogenesis - part 2. Headache 2006; 46: 365-386. Go to original source... Go to PubMed...
- Mastík J. Léčba menstruační a perimenstruační migrény. Neurol. pro praxi 2008; (9)6: 356-360.
- Silberstein SD, Lipton RB, Dalessio DJ. Wolff´s Headache and Other Head Pain. New York: Oxford University Press 2001: 625.
- Unzeitig V. Aktivita hormonů a jejich vliv na organismus uživatelky kombinované orální kontracepce (COC). Moderní gynekologie a porodnictví 2005; 14(1)Suppl.: 3-10.